Stockholders' Equity - Narrative (Details)				12 Months Ended			15 Months Ended	19 Months Ended	108 Months Ended
	Jun. 03, 2024 shares	Jan. 01, 2016 shares	Jun. 30, 2015 shares	Dec. 31, 2024 USD ($) vote $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($)	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2024 USD ($) $ / shares shares	Dec. 31, 2024 USD ($) $ / shares shares	Sep. 10, 2024 $ / shares	Jun. 05, 2023 shares	Oct. 31, 2022 USD ($)	Nov. 14, 2013 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares)				200,000,000	200,000,000		200,000,000	200,000,000	200,000,000
Common stock, par value (in usd per share) | $ / shares				$ 0.001	$ 0.001		$ 0.001	$ 0.001	$ 0.001	$ 0.001
Number of voting rights | vote				1
Granted (in shares)				0
Exercises in period, intrinsic value | $				$ 22,174,000	$ 2,469,000	$ 1,612,000
Unrecognized compensation cost | $				$ 0				$ 0	$ 0
Share repurchase program, authorized amount | $												$ 100,000,000
Repurchase of common stock (in shares)				0			4,415,093
Amount of common stock repurchased under share repurchase program | $					43,522,000	$ 56,445,000	$ 99,967,000
Restricted Stock Units and Performance Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost not yet recognized | $				$ 181,874,000	$ 209,546,000		$ 209,546,000	$ 181,874,000	$ 181,874,000
Compensation cost not yet recognized, period for recognition				2 years 29 days	2 years 3 months 21 days
The 2013 Omnibus Equity Award Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance (in shares)													5,713,899
Capital shares reserved for future issuance, annual increase, maximum (in shares)				27,579,672				27,579,672	27,579,672
Vesting period (in years)				4 years
Granted (in shares)				0				0
Shares available for grant (in shares)				0				0	0
The 2013 Omnibus Equity Award Plan | Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)				1 year
The 2023 Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance (in shares)											5,500,000
Granted (in shares)				0
Polyrize Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)				0
Shares available for grant (in shares)				0				0	0
2023 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of additional shares authorized (in shares)	4,400,000
2015 ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of additional shares authorized (in shares)									3,908,910
Maximum employee subscription rate			15.00%
Purchase price of common stock, percent			85.00%
Number of shares authorized (in shares)			1,500,000
Percent of shares increase, employee stock purchase plan		1.00%
Common stock availability threshold, employee stock purchase plan		2.00%
Shares increase threshold, employee stock purchase plan (in shares)		1,200,000